About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Understanding of Old Antibiotics Could Lead to Future Drugs

by Bidita Debnath on December 5, 2017 at 11:57 PM
Font : A-A+

Understanding of Old Antibiotics Could Lead to Future Drugs

Thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute, tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs.

Led by Professor David Roper at Warwick's School of Life Sciences and Dr Luiz Pedro Carvalho from The Francis Crick Institute, a paper published in Nature Communications reveals a deeper understanding of how the antibiotic D-cycloserine uniquely works at a molecular level.

Advertisement


This could lead to more effective future antibiotics - which are desperately needed to fight increasingly drug-resistant and deadly bacteria.

D-cycloserine is an old antibiotic drug which is effective against many microbial diseases such as tuberculosis, but is often used as a second line treatment, because of some adverse side-effects.
Advertisement

The researchers have now discovered that it acts chemically in very different ways on multiple bacterial targets - possibly the only antibiotic in the world to do so.

The drug attacks bacteria by inhibiting two separate enzymes (D-alanine racemase and D-alanine--D-alanine ligase) each required to build and maintain the structural integrity of bacterial cell walls.

With the D-alanine racemase enzyme, it is known that the drug forms a molecular bond with a chemical group required for the enzyme activity, stopping it from working.

The researchers have observed, for the first time, how D-cycloserine inhibits the D-alanine-D-alanine ligase enzyme.

David Roper, who is Professor of Biochemistry and Structural Biology at the University Warwick, commented: "In this new discovery, we see that D-cycloserine binds to the D-alanine-D-alanine ligase enzyme and becomes chemically modified on the enzyme. The chemical species formed here has never been seen before.

"We now understand fully how this antibiotic drug can have totally different methods of working on separate targets. This appears to be a unique amongst the antibiotics."

Dr Luiz Pedro Carvalho, from the Mycobacterial Metabolism and Antibiotic Research Laboratory at the Francis Crick Institute, said: "Perhaps more important than how D-cycloserine works, this study highlights an increasingly obvious fact: we know much less than we think about how antibiotics really work and how bacteria become resistant.

"Only by truly understanding molecular and cellular events caused by antibiotics or in response to their presence will we truly understand how to make improved drugs, which are much needed in face of the current threat of antibiotic resistance."

A longer term goal will be to modify the structure of D-cycloserine, so that it more closely resembles the newly discovered chemical species, and in so doing produce an antibiotic that is more specific and avoids some of adverse side effects of D-cycloserine - enabling its wider use in the fight against antibiotic resistant infections.

There is a global crisis in healthcare because bacterial infections are becoming increasingly resistant to the antibiotic drugs we use to treat them.

Antimicrobial resistance threatens many aspects of human activity including medicine and agriculture and could lead to more deaths than cancer. The research, 'Inhibition of D-Ala: D-Ala ligase through a novel phosphorylated antibiotic', is published in Nature Communications.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Memory Loss - Can it be Recovered?
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity MRSA - The Super Bug Drugs Banned in India Antibiotics Eye Infections Natural Antibiotics to Fight Bacterial Infections Vancomycin-Resistant Enterococci (VRE) Boils - Treatment by Drugs Multiple Drug Allergy Syndrome Interaction of Antibiotics with Dairy Products 

Recommended Reading
TB Drug Resistance is Not More Likely to Evolve in HIV-Positive Patients
A parallel HIV pandemic amplifies the tuberculosis epidemic, with ongoing efforts around the world ....
India Government to Add More AIDS, TB Drugs to Essential Medicines List
India has about 2.2 million TB patients, the highest in the world, and an estimated 2.1 million are ...
PET Scans Help Identify Effective TB Drugs
PET/CT scan can show whether or not a treatment drug is able to clear tuberculosis (TB) lung ......
Manner in Which TB Drug Attacks Its Target Uncovered
A clue to understanding how the most important drug for tuberculosis works to attack dormant TB ......
Antibiotics
Antibiotics are among the most used and abused medications. This article explains some general featu...
Boils - Treatment by Drugs
Diabetes patients have reduced immunity, which makes them more susceptible to skin infections like b...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Eye Infections
Eye infection is a common problem that often causes pain and discomfort to the eyes. Common symptoms...
Interaction of Antibiotics with Dairy Products
Antibiotics like tetracyclines and fluoroquinolones used in the treatment of bacterial infections in...
MRSA - The Super Bug
MRSA infection is the most dreaded hospital or community acquired infection that can become ......
Multiple Drug Allergy Syndrome
Multiple drug allergy syndrome or multiple drug hypersensitivity syndrome is a condition that causes...
Natural Antibiotics to Fight Bacterial Infections
Fighting infections the natural way and preventing them is always more effective than consuming medi...
Vancomycin-Resistant Enterococci (VRE)
Enterococci are a group of gram-negative bacteria that mostly inhabit the human gut. At present ther...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use